University of Kentucky’s Sanders-Brown Receives Continued Funding to Research Vascular Cognitive Impairment and Dementia Biomarkers

Researchers at the University of Kentucky’s Sanders-Brown Center on Aging recently received a five-year grant renewal of their MarkVCID program from the National Institutes of Health (NIH). The award total is more than $6 million.

UK HealthCare Launches Pediatric Neuroendocrine Tumor Program

UK HealthCare recently launched a new Pediatric Neuroendocrine Tumor Clinical and Research Program to improve treatment for children diagnosed with or at high risk for developing rare neuroendocrine tumors (NETs). This program is a joint effort between the University of Kentucky Markey Cancer Center and the Kentucky Children’s Hospital and is one of only a handful of centers specializing in this field in the world.

Scholarship and Practice of Undergraduate Research Issue Features Nontraditional Approaches to Research

The winter 2020 issue of Scholarship and Practice of Undergraduate Research (SPUR), the academic journal of the Council on Undergraduate Research, focuses on unusual approaches to undergraduate research such as research for chefs and a video game for biology majors.

Sanders-Brown Study Leads to Potential for a New Treatment Approach to Alzheimer’s Disease

The paper explains that current therapeutic approaches to the treatment of Alzheimer’s disease focus on the major pathological hallmarks of the disease which are amyloid plaques and neurofibrillary tangles. They are the requirements for a diagnosis of Alzheimer’s disease. However, the authors say there has been an explosion of genetic data suggesting the risk for sporadic Alzheimer’s disease is driven by several other factors including neuroinflammation, membrane turnover and storage, and lipid metabolism.

University of Kentucky, Penn Researchers Provide Insights into Newly Characterized Form of Dementia

Working with their colleagues at the University of Pennsylvania, researchers at the University of Kentucky have found that they can differentiate between subtypes of dementia inducing brain disease. “For the first time we created criteria that could differentiate between frontotemporal dementia (FTD) and a common Alzheimer’s ‘mimic’ called LATE disease,” explained Dr. Peter Nelson of the Sanders-Brown Center on Aging at the University of Kentucky.

University of Kentucky’s Sanders-Brown Center on Aging Facilitates First Participant in Worldwide Drug Study

Researchers at the University of Kentucky’s Sanders-Brown Center on Aging (SBCoA) recently screened the first participant in the world for what is known as the AHEAD 3-45 study. This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping this study finds that BAN2401 does just that and will ultimately help prevent Alzheimer’s disease.

It’s not just Alzheimer’s disease: Sanders-Brown research highlights form of severe dementia

The long-running study on aging and brain health at the University of Kentucky’s Sanders-Brown Center on Aging Alzheimer’s Disease Center has once again resulted in important new findings – highlighting a complex and under-recognized form of dementia.

University of Kentucky Researcher Leads First Human Study of Drug Targeting Brain Inflammation

A study examining MW189 in healthy adult volunteers was performed by a collaborative team from the University of Kentucky, Duke University and Northwestern University. The work by Van Eldik and the rest of the team is substantial as it is the first time MW189 had been tested in humans.

University of Kentucky Expert, Economist Michael Clark Weighs in on Impact of COVID-19

LEXINGTON, Ky. (April 7, 2020) — As the novel coronavirus (COVID-19) continues to spread across the U.S., the government is responding in unprecedented ways. Measures to protect the nation’s most vulnerable citizens — though necessary — will have a lasting impact on…

University of Kentucky Partners With Gen.G to Build Community Through Games

The partnership between UK and Gen.G will develop wholly new pathways for student recruitment, classroom and internship opportunities; research avenues for scholars across a variety of colleges; and professional development for alumni.